MiR-153 inhibits migration and invasion of human non-small-cell lung cancer by targeting ADAM19

Biochemical and Biophysical Research Communications

Volumn 456, Issue 1, 2015, Pages 385-391

  Shan, Nianxi ^a   Shen, Liangfang ^a   Wang, Jun ^a   He, Dan ^a   Duan, Chaojun ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

ADAM19; Cell invasion; Cell migration; Human non small cell lung cancer; miR 153

Indexed keywords

ADAM PROTEIN; ADAM19 PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 153; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ADAM19 PROTEIN, HUMAN; MIRN153 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CANCER TISSUE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUCIFERASE ASSAY; LUNG CANCER CELL LINE; LYMPH NODE; MALE; NON SMALL CELL LUNG CANCER; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; AGED; CELL MOTION; GENE EXPRESSION REGULATION; LUNG TUMOR; METABOLISM; MIDDLE AGED; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ADAM PROTEINS; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS;

EID: 84919666249     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.11.093     Document Type: Article

References (24)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J. Clin. 61 2011 69 90
2. P. Goldstraw, D. Ball, J.R. Jett, T. Le Chevalier, E. Lim, A.G. Nicholson, and F.A. Shepherd Non-small-cell lung cancer Lancet 378 2011 1727 1740
3. A. Custodio, M. Mendez, and M. Provencio Targeted therapies for advanced non-small-cell lung cancer: current status and future implications Cancer Treat. Rev. 38 2012 36 53
4. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
5. B.M. Engels, and G. Hutvagner Principles and effects of microRNA-mediated post-transcriptional gene regulation Oncogene 25 2006 6163 6169
6. G.A. Calin, and C.M. Croce MicroRNA-cancer connection: the beginning of a new tale Cancer Res. 66 2006 7390 7394
7. S. Zhao, Y. Deng, Y. Liu, X. Chen, G. Yang, Y. Mu, D. Zhang, J. Kang, and Z. Wu MicroRNA-153 is tumor suppressive in glioblastoma stem cells Mol. Biol. Rep. 40 2013 2789 2798
8. T.H. Kim, Y.K. Kim, Y. Kwon, J.H. Heo, H. Kang, G. Kim, and H.J. An Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours Histopathology 57 2010 734 743
9. Q. Xu, Q. Sun, J. Zhang, J. Yu, W. Chen, and Z. Zhang Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer Carcinogenesis 34 2013 539 549
10. L. Zhang, K. Pickard, V. Jenei, M.D. Bullock, A. Bruce, R. Mitter, G. Kelly, C. Paraskeva, J. Strefford, J. Primrose, G.J. Thomas, G. Packham, and A.H. Mirnezami MiR-153 supports colorectal cancer progression via pleiotropic effects that enhance invasion and chemotherapeutic resistance Cancer Res. 73 2013 6435 6447
11. Z. Wu, B. He, J. He, and X. Mao Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer Prostate 73 2013 596 604
12. Y. Yuan, W. Du, Y. Wang, C. Xu, J. Wang, Y. Zhang, H. Wang, J. Ju, L. Zhao, Z. Wang, Y. Lu, B. Cai, and Z. Pan Suppression of AKT expression by miR-153 produced anti-tumor activity in lung cancer Int. J. Cancer 2014 10.1002/ijc.29103
13. M.V. Iorio, and C.M. Croce MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review EMBO Mol. Med. 4 2012 143 159
14. A. Ventura, and T. Jacks MicroRNAs and cancer: short RNAs go a long way Cell 136 2009 586 591
15. R. Garzon, and C.M. Croce MicroRNAs in normal and malignant hematopoiesis Curr. Opin. Hematol. 15 2008 352 358
16. J. Xu, X. Liao, and C. Wong Downregulations of B-cell lymphoma 2 and myeloid cell leukemia sequence 1 by microRNA 153 induce apoptosis in a glioblastoma cell line DBTRG-05MG Int. J. Cancer 126 2010 1029 1035
17. D.R. Edwards, M.M. Handsley, and C.J. Pennington The ADAM metalloproteinases Mol. Aspects Med. 29 2008 258 289
18. T.G. Wolfsberg, P. Primakoff, D.G. Myles, and J.M. White ADAM, a novel family of membrane proteins containing A Disintegrin and Metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions J. Cell Biol. 131 1995 275 278
19. M.J. Duffy, E. McKiernan, N. O'Donovan, and P.M. McGowan Role of ADAMs in cancer formation and progression Clin. Cancer Res. 15 2009 1140 1144
20. S. Mochizuki, and Y. Okada ADAMs in cancer cell proliferation and progression Cancer Sci. 98 2007 621 628
21. D. Wildeboer, S. Naus, Q.X. Amy Sang, J.W. Bartsch, and A. Pagenstecher Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness J. Neuropathol. Exp. Neurol. 65 2006 516 527
22. A. Dijkstra, D.S. Postma, J.A. Noordhoek, M.E. Lodewijk, H.F. Kauffman, N.H. ten Hacken, and W. Timens Expression of ADAMs ("a disintegrin and metalloprotease") in the human lung Virchows Arch. 454 2009 441 449
23. D.T. Keating, D.M. Sadlier, A. Patricelli, S.M. Smith, D. Walls, J.J. Egan, and P.P. Doran Microarray identifies ADAM family members as key responders to TGF-beta1 in alveolar epithelial cells Respir. Res. 7 2006 114
24. W.B. Melenhorst, M.C. van den Heuvel, A. Timmer, S. Huitema, M. Bulthuis, W. Timens, and H. van Goor ADAM19 expression in human nephrogenesis and renal disease: associations with clinical and structural deterioration Kidney Int. 70 2006 1269 1278